Somatuline Auto Gel 120mg (Lanreotide Injection) 120mg

Somatuline Auto Gel 120mg is a prescription injection used for hormone-related conditions. It contains lanreotide to help regulate hormone levels in the body. This 120mg strength gel is designed for subcutaneous use. Store between 2-8°C to maintain potency.

Strength

120mg

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Ipsen

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Somatuline Auto Gel 120mg is used to treat acromegaly and symptoms caused by neuroendocrine tumors. It helps manage excessive growth hormone levels and associated conditions like gigantism. This medication may also be used for other hormone-related disorders as prescribed by a healthcare provider. It works by reducing hormone secretion in the body.

Side Effects

Somatuline Auto Gel 120mg helps reduce symptoms such as headaches, sweating, and joint pain associated with hormone imbalances. Users may experience improved comfort and reduced tumor-related symptoms over time. The gel formulation provides steady hormone regulation throughout the dosing period.

Precautions & Warnings

Keep Somatuline Auto Gel 120mg refrigerated between 2-8°C and protect it from light. Do not freeze the medication or expose it to high temperatures. Always check the expiration date before use. Discard any unused portion after the prescribed dose is administered. Consult a healthcare provider if you experience severe injection site reactions.

Avoid Interactions

Somatuline Auto Gel 120mg may interact with medications that affect heart rhythm, such as antiarrhythmics. Caution is advised when combining it with drugs that alter gastrointestinal motility. Always inform your healthcare provider about all medications you are taking. Monitor for changes in blood sugar levels if you have diabetes.

References

Frequently Asked Questions

It is used to treat acromegaly and symptoms from neuroendocrine tumors by regulating hormone levels.

It is given as a subcutaneous injection, typically every 28 days.

No, it must be refrigerated between 2-8°C to maintain its effectiveness.

Common effects may include injection site reactions, gastrointestinal discomfort, or changes in blood sugar.

Yes, this medication is prescription-only and should be used under medical supervision.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.